Nilay Danış et al. 2019. Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection. Turkish Journal of Gastroenterology. 30, 8 (Aug. 2019), 695–701.